GMP Audit & GMP Consulting

ProPharma specializes in delivering comprehensive current Good Manufacturing Practice (cGMP) Audits and GMP Consulting services, designed to ensure compliance with regulatory standards and optimize manufacturing processes. With extensive worldwide expertise in the pharmaceutical, biotechnology, medical device, advanced therapy, and other healthcare industries, our consulting experts are committed to helping our clients maintain the highest levels of compliance, quality, and efficiency.

Robotic manufacturing arms working on devices

Proactive  ⇔  Reactive

Our GxP compliance team supports a complete suite of cGMP consulting options ranging from proactive to reactive needs.

Innovation icon

Preventative

  • GMP Vendor Qualification
  • GMP and QMS Gap Analysis
  • Mock PAI / BLI Readiness
  • Internal GMP audit
  • QMS Building / Revision
Spinning cog icon

Maintenance

  • Maintenance GMP vendor audit
  • GMP Desktop / Checklist assessments
Compliance

Remedial

  • cGMP consulting services
  • For-Cause GMP Audits
  • Health Authority Response
  • Observation, 483, Consent Decree support.

GxP Audit Experience

ProPharma’s Global Auditing Program has conducted 1,000s of Audits for hundreds of global companies, across all GxP’s and phases. With offices and quality & compliance consultants located all over the world, ProPharma offers the availability to execute audits in different GxP areas on a global basis with diverse language skills, creating efficiencies in both time and money. Our large team of qualified auditors have a breadth of expertise across the entire development and regulatory spectrum (GMP, GCP, GLP, GCLP, GPV, ISO-13485, CSV, Data Integrity, etc.).

Hands typing on laptop displaying diagram of DNA double helix
People working at a table with medical and computer devices

GMP Audit Coordination Team

Our Audit Coordinators make your role easier, they provide facilitation and management of audit logistics, periodic progress meetings, timelines, and completion of deliverables between client/sponsor, auditor, and auditee.

The ProPharma Coordination team is connected to our network of Subject Matter Expert Compliance Consultants who provide technical support and guidance for compliance processes, peer review of deliverables and outputs as well as access to the entire catalogue of ProPharma’s services, forming our Global Auditing Team.

Our Global Auditing Team brings unparalleled collaboration, consultation, and right-sized compliance options to your GMP audit needs with a broad compliance reach.

GxP Compliance Reach

Popular Compliance Focus’

Sampling of Commonly Audited Compliance Standards

Pharmaceuticals, Raw Materials, Components, Packaging

21 CFR 210/211, EudraLex Volume 4, ICH Q1-14, Annex 1, ISO 9001

Biologics

21 CFR 211, 21 CFR 610, ICH Q5

Medical Devices

21 CFR 820 / ISO 13485 / (EU MDR) 745/2017

Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/P)

21 CFR 211, 21 CFR 1271

Compounding Pharmacies

USP <795>, USP <797>, 21 CFR 211

Active Pharmaceutical Ingredients (API)

21 CFR 210/211 ICH Q7, Annex 1

Cosmetic Products

ISO 22716 Cosmetics, FDA 21 CFR 700/701- MOCRA 2022

Computer Systems and Software / Digital IT / IS

21 CFR 11, GAMP 5, Annex 11

Excipients

USP <1078>, IPEC-PQG GMP Guide

Laboratories – GMP

GMP, ICH Quality Standards

Positron Emission Tomography (PET) Drugs

21 CFR 212, Eudralex 4, Annex 3

Dietary Supplements

21 CFR 111

Third-Party Logistics (3PL)

USP <1083>, WHO Annex 5 & 9, GDP 2013/C 343/01

Qualified Person (QP, QPPV) / Responsible Person (RP)

Audits, declarations, MIA Support 

ProPharma's GMP Audit Strategies

propharma-gmp-audit-services
Gradient Image

With respect to GMP Audits

We follow standardized practices relevant to local Health Authorities applicable to the individual client, sponsor, and/or auditee or are flexible to design a focused or for-cause audit specific to a direct client compliance need.

ProPharma’s Standard Scope and Methodology

Our GMP Auditing service was developed, and the process has been optimized over the years, which our customers find to be compliant, thorough, and efficient.

Spinning cog icon

Coordination & Preparation

  • Coordination Setup
  • Auditor Briefing Meeting
  • Agenda/Audit Plan
Document search icon

Audit Execution

  • On-site or Virtual
  • Audit Conduct
  • Close Out Meetings
Clinical technology services icon

Post Audit

Commissioning, qualification, validation icon

Pre-Audit Planning

Pre-Audit Planning

Pharmacovigilance

On-Site and Remote Audits

On-Site and Remote Audits

Product compliant intake icon

Risk Assessment

Risk Assessment

Submissions icon

Report and Recommendations

Report and Recommendations

Global literature review icon

Corrective and Preventative Action

Corrective and Preventative Action

Pre-Audit Planning

Thorough preparation including document review and audit plan development. Following client provided procedures or through ProPharma’s established process.

Business professionals collaborating in an office around a laptop

On-Site and Remote Audits

Detailed compliance audits of facilities, equipment, processes, and documentation to assess compliance with GMP standards may be conducted in person or remotely. Our Audit Coordination Team can even assist with remote auditing technologies.

Two lab workers looking at material in a petridish

Risk Assessment

Our default auditing approach is to identify and evaluate the impact of potential compliance risks and potential areas of concern.

Business people analyzing and planning

Report and Recommendations

As a standard audit output deliverable, audits are documented in full narrative comprehensive audit reports with actionable recommendations for addressing deficiencies and enhancing compliance. Alternate formats such as compliance checklist or matrices, or client provided templates are available.

Health care professionals reviewing computer monitors inside an examination room

Corrective and Preventative Action

Post audit, whether it is administrative, compliance adequacy review, or direct remediation support, ProPharma’s team can support your firm’s needs upon request.

Business professionals smiling at a desk reviewing data

Our auditors are knowledgeable, inquisitive, friendly, and collaborative. Auditors are assigned on a per audit basis, based on how their background experiences and expertise are aligned to the audit scope and project timing. ProPharma’s team is adaptive and flexible to each client’s needs. Key areas of GMP Audit focus are:

Key Areas of Focus During GMP Audits

Computer System Validation icon

Quality Management Systems

Evaluation of quality control and assurance processes.

Quality Management Systems

Evaluation of quality control and assurance processes.

Read Less
Adverse event intake icon

Production Processes

Examination of manufacturing practices, process controls, and batch documentation.

Production Processes

Examination of manufacturing practices, process controls, and batch documentation.

Read Less
Service icon

Facility and Equipment

Inspection of physical facilities and equipment maintenance programs.

Facility and Equipment

Inspection of physical facilities and equipment maintenance programs.

Read Less
Innovation icon

Personnel Training

Assessment of staff qualifications, training programs, and competency records.

Personnel Training

Assessment of staff qualifications, training programs, and competency records.

Read Less
R&D Technology icon

Supply Chain Management

Review of supplier qualification processes and material handling procedures.

Supply Chain Management

Review of supplier qualification processes and material handling procedures.

Read Less

ProPharma’s GMP Consulting Services

ProPharma’s cGMP consulting experts deliver tailored Quality System compliance solutions to our clients. We specialize in guiding pharmaceutical, device, biologics, and targeted therapies companies through the complexities of health authority requirements, ensuring that their processes meet stringent quality expectations. With our expert team of compliance consultants, you can confidently navigate the evolving landscape of GMP regulations, ultimately enhancing quality, safety, and efficacy.

Confident worker woman looking at camera
Business worker working around a conference table

Consulting Services Offered

  • Quality Compliance: Guidance on meeting FDA, EMA, MHRA, and other international health authority requirements.
  • Quality System Development: Assistance in evaluating / assessing current stated and developing and implementing robust quality management systems.
  • Remediation Support: Support in addressing regulatory findings, including CAPA (Corrective and Preventive Action) planning and implementation.

GMP Consulting Services

Computer System Validation icon

Quality Management Systems

  • Implementation, Remediation, and Maintenance - EMEA/MHRA/FDA - Pharma and Medical Device / Diagnostics
  • eQMS - Dot Compliance

Quality Management Systems

  • Implementation, Remediation, and Maintenance - EMEA/MHRA/FDA - Pharma and Medical Device / Diagnostics
  • eQMS - Dot Compliance
Read Less
Quality & Compliance icon

Quality Assurance

Read More

Quality Assurance

Read Less
Expert Witness icon

Pre-Approval Inspection and Auditing

Pre-Approval Inspection and Auditing

Read Less
Regulatory Sciences icon

Remediation

FDA Action (483 Observations, Warning Letters, Consent Decrees) Remediation

Remediation

FDA Action (483 Observations, Warning Letters, Consent Decrees) Remediation

Read Less
Program and project management icon

Quality Control

  • EM and QC Program Development, Analysis Testing, Method Validation

Quality Control

  • EM and QC Program Development, Analysis Testing, Method Validation
Read Less
Medical device icon

Additional GMP Audits & Consulting Services

Read More

Additional GMP Audits & Consulting Services

Read Less

GMP Consulting Approach

  • Assessment and Analysis: In-depth analysis of current practices and identification of improvement opportunities. 
  • Strategic Planning: Development of tailored strategies to enhance compliance and operational efficiency. 
  • Implementation Support: Hands-on assistance with the implementation of recommended changes and ongoing support to ensure sustained improvements. 
  • Project & Program Management: direction and monitoring of milestone deliverables and project progression: 
  • Performance Monitoring: Assistance with vendor management, compliance oversight, and auditing to monitor compliance. 
Hands gesturing around a table with various charts and graphs
Group of professional women talking in a lobby

Our GMP Auditing Expertise:

Our Consulting team is composed of seasoned professionals with years of experience in GMP environments and best practices. Coupling deep understanding of the expectations and challenges of manufacturing in regulated environments, we ensure our clients receive the highest level of service and outcome.

Benefits of Partnering with Us

  • Enhanced Compliance: Achieve and “right-sized” compliance with relevant GMP regulations aligned with your company’s unique quality processes and business requirements.
  • Improved Efficiency: Optimize quality processes for better productivity and cost savings.
  • Risk Mitigation: Identify and mitigate compliance risks to prevent costly regulatory actions.
  • Knowledge Transfer: Empower your team with the knowledge and skills needed to sustain high standards of quality and compliance.
Business professionals smiling at a desk reviewing data

ProPharma GMP Consulting Services

By partnering with ProPharma, you can be confident in your ability to meet regulatory requirements in your operations. Our commitment to quality and customer satisfaction is central to everything we do, ensuring that you receive the best possible support and outcomes.

News & Insights

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

July 22, 2025

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

Discover how pharma marketers can build effective, compliant omnichannel marketing strategies to drive engagement and meet regulatory requirements.

Mastering Clinical Trial Submissions in Europe: A Guide for Drug Developers

July 21, 2025

Mastering Clinical Trial Submissions in Europe: A Guide for Drug Developers

Discover how to navigate EU clinical trial submissions with confidence. Learn key strategies for CTA success, managing RFIs, and ensuring compliance under EU CTR, MDR, and IVDR.

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

July 21, 2025

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device ...

Learn why relying solely on FMEA for medical device risk management falls short and how to adopt a more comprehensive approach to meet ISO 14971 standards.

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Case Study From Drafts to First Patient in Record Time - ProPharma

July 8, 2025

From Drafts to First Patient in Record Time

Launching a global clinical study from draft documents, the team achieved US first patient in in 3.5 months and met ambitious global submission timelines. Strong collaboration, proactive planning,...

Whitepapers FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submission

June 23, 2025

FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submiss...

A Strategic Guide to Early FDA Engagement for a Streamlined NDA Pathway For drug developers leveraging the 505(b)(2) NDA pathway, early engagement with FDA is a critical determinant of regulatory...

Case Study Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina - ProPharma

June 18, 2025

Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina

Acting as Marketing Authorization Holder in Bosnia and Herzegovina, Clinres—a ProPharma company—helped a global pharma client overcome regulatory delays, misaligned planning, and seasonal launch...

Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

News & Insights

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

July 22, 2025

Omnichannel Marketing in Pharma: A Strategy Guide for Regulatory Compliance

Discover how pharma marketers can build effective, compliant omnichannel marketing strategies to drive engagement and meet regulatory requirements.

Mastering Clinical Trial Submissions in Europe: A Guide for Drug Developers

July 21, 2025

Mastering Clinical Trial Submissions in Europe: A Guide for Drug Developers

Discover how to navigate EU clinical trial submissions with confidence. Learn key strategies for CTA success, managing RFIs, and ensuring compliance under EU CTR, MDR, and IVDR.

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device Lifecycle Management

July 21, 2025

FMEA Is Not a Crystal Ball: Why You're Missing Critical Risks in Medical Device ...

Learn why relying solely on FMEA for medical device risk management falls short and how to adopt a more comprehensive approach to meet ISO 14971 standards.

Previous Post Arrow Next Post Arrow
ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice President, Labeling & Strategy to Advance Strategic Labeling & Promotional Review

July 8, 2025

ProPharma Appoints Marshall Florence, Former FDA Labeling Expert, as Vice Presid...

ProPharma appoints former FDA labeling expert as VP, Labeling & Strategy, enhancing strategic labeling, promotional review, and regulatory consulting expertise to accelerate drug development and...

ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Appoints Brian Tuttle as Chief Financial Officer

October 21, 2024

ProPharma Appoints Brian Tuttle as Chief Financial Officer

ProPharma appoints Brian Tuttle as CFO to drive financial strategy and accelerate global growth, leveraging his 20 years of life sciences industry experience.

Previous Post Arrow Next Post Arrow
ProPharma Recognized for AI Excellence at ECCCSA

January 31, 2025

ProPharma Recognized for AI Excellence at ECCCSA

ProPharma wins Silver at ECCCSA for AI innovation in Medical Information, enhancing efficiency and quality in delivering accurate medical information.

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

October 9, 2024

ProPharma Receives 2024 CPHI Regulatory and Compliance Award

ProPharma wins CPHI Pharma Award for excellence in regulatory and compliance innovation, enhancing efficiency and accelerating market access for life-saving therapies.

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

September 24, 2024

ProPharma Honored in the 2024 Clinical Trials Excellence Awards

ProPharma honored with Clinical Trials Excellence Award 2024, recognizing their outstanding contributions in the pharmaceutical industry.

Previous Award Arrow Next Award Arrow
Case Study From Drafts to First Patient in Record Time - ProPharma

July 8, 2025

From Drafts to First Patient in Record Time

Launching a global clinical study from draft documents, the team achieved US first patient in in 3.5 months and met ambitious global submission timelines. Strong collaboration, proactive planning,...

Whitepapers FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submission

June 23, 2025

FDA Pre-IND Meetings: Setting Yourself up For a Successful 505(b)(2) NDA Submiss...

A Strategic Guide to Early FDA Engagement for a Streamlined NDA Pathway For drug developers leveraging the 505(b)(2) NDA pathway, early engagement with FDA is a critical determinant of regulatory...

Case Study Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina - ProPharma

June 18, 2025

Local Expertise, Local Knowledge: MAH in Bosnia and Herzegovina

Acting as Marketing Authorization Holder in Bosnia and Herzegovina, Clinres—a ProPharma company—helped a global pharma client overcome regulatory delays, misaligned planning, and seasonal launch...

Previous Resource Arrow Next Resource Arrow
Avoiding Common Pitfalls During FDA Inspections

July 29, 2025

Avoiding Common Pitfalls During FDA Inspections

Starting August 2025, the FDA will conduct unannounced inspections at non-U.S. sites. This webinar explores common inspection pitfalls and how to maintain global inspection readiness with expert...

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

July 22, 2025

Inside FDA Review: Crafting a Quality ANDA Labeling Submission

Gain rare, insider insight into the FDA’s expectations for ANDA submissions in this session led by Marshall Florence, PharmD, a former FDA reviewer who recently joined our team. With firsthand...

MAH Essentials: Ensuring Compliance for European Market Entry

July 10, 2025

MAH Essentials: Ensuring Compliance for European Market Entry

This webinar covers the key responsibilities of Marketing Authorization Applicants/Holders and Qualified Persons in the EEA/UK, including pharmacovigilance requirements, legal entity setup, and...

Previous Webinar Arrow Next Webinar Arrow